These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26212157)

  • 1. Preclinical testing of drug delivery systems to bone.
    van Griensven M
    Adv Drug Deliv Rev; 2015 Nov; 94():151-64. PubMed ID: 26212157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biomimetic growth factor delivery strategy for enhanced regeneration of iliac crest defects.
    Huri PY; Huri G; Yasar U; Ucar Y; Dikmen N; Hasirci N; Hasirci V
    Biomed Mater; 2013 Aug; 8(4):045009. PubMed ID: 23782488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenic growth peptide incorporated into PLGA scaffolds accelerates healing of segmental long bone defects in rabbits.
    Shuqiang M; Kunzheng W; Xiaoqiang D; Wei W; Mingyu Z; Daocheng W
    J Plast Reconstr Aesthet Surg; 2008 Dec; 61(12):1558-60. PubMed ID: 18676213
    [No Abstract]   [Full Text] [Related]  

  • 4. Carrier systems and application of growth factors in orthopaedics.
    Schmidmaier G; Schwabe P; Strobel C; Wildemann B
    Injury; 2008 Sep; 39 Suppl 2():S37-43. PubMed ID: 18804572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of growth factors for bone regeneration.
    Yun YR; Jang JH; Jeon E; Kang W; Lee S; Won JE; Kim HW; Wall I
    Regen Med; 2012 May; 7(3):369-85. PubMed ID: 22594329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The scope and sequence of growth factor delivery for vascularized bone tissue regeneration.
    Bayer EA; Gottardi R; Fedorchak MV; Little SR
    J Control Release; 2015 Dec; 219():129-140. PubMed ID: 26264834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications.
    Laurencin CT; Ashe KM; Henry N; Kan HM; Lo KW
    Drug Discov Today; 2014 Jun; 19(6):794-800. PubMed ID: 24508820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-controlled release system of drugs for bone regeneration.
    Kim YH; Tabata Y
    Adv Drug Deliv Rev; 2015 Nov; 94():28-40. PubMed ID: 26079284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone regeneration with biomaterials and active molecules delivery.
    D' Este M; Eglin D; Alini M; Kyllonen L
    Curr Pharm Biotechnol; 2015; 16(7):582-605. PubMed ID: 25658379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of drugs in electrosprayed nanoparticles for bone tissue engineering.
    Jayaraman P; Gandhimathi C; Venugopal JR; Becker DL; Ramakrishna S; Srinivasan DK
    Adv Drug Deliv Rev; 2015 Nov; 94():77-95. PubMed ID: 26415888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of dual delivery systems for bone tissue engineering.
    Farokhi M; Mottaghitalab F; Shokrgozar MA; Ou KL; Mao C; Hosseinkhani H
    J Control Release; 2016 Mar; 225():152-69. PubMed ID: 26805518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local and targeted drug delivery for bone regeneration.
    Newman MR; Benoit DS
    Curr Opin Biotechnol; 2016 Aug; 40():125-132. PubMed ID: 27064433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced angiogenesis and osteogenesis in critical bone defects by the controlled release of BMP-2 and VEGF: implantation of electron beam melting-fabricated porous Ti6Al4V scaffolds incorporating growth factor-doped fibrin glue.
    Lv J; Xiu P; Tan J; Jia Z; Cai H; Liu Z
    Biomed Mater; 2015 Jun; 10(3):035013. PubMed ID: 26107105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting scaffolds for bone and cartilage regeneration.
    Huang CL; Lee WL; Loo JS
    Drug Discov Today; 2014 Jun; 19(6):714-24. PubMed ID: 24239726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process.
    Issa JP; Bentley MV; Iyomasa MM; Sebald W; De Albuquerque RF
    Anat Histol Embryol; 2008 Jun; 37(3):181-7. PubMed ID: 18070240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of growth factors for tissue regeneration and wound healing.
    Koria P
    BioDrugs; 2012 Jun; 26(3):163-75. PubMed ID: 22500904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-clinical in vivo models for the screening of bone biomaterials for oral/craniofacial indications: focus on small-animal models.
    Stavropoulos A; Sculean A; Bosshardt DD; Buser D; Klinge B
    Periodontol 2000; 2015 Jun; 68(1):55-65. PubMed ID: 25867979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.
    Lee SH; Shin H
    Adv Drug Deliv Rev; 2007 May; 59(4-5):339-59. PubMed ID: 17499384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial gene therapy accelerates bone regeneration: non-viral dual delivery of VEGF and BMP2 in a collagen-nanohydroxyapatite scaffold.
    Curtin CM; Tierney EG; McSorley K; Cryan SA; Duffy GP; O'Brien FJ
    Adv Healthc Mater; 2015 Jan; 4(2):223-7. PubMed ID: 25125073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenopus laevis as a novel model to study long bone critical-size defect repair by growth factor-mediated regeneration.
    Feng L; Milner DJ; Xia C; Nye HL; Redwood P; Cameron JA; Stocum DL; Fang N; Jasiuk I
    Tissue Eng Part A; 2011 Mar; 17(5-6):691-701. PubMed ID: 20929280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.